New and better marker for assessing patients after cardiac arrest

laboratory
Credit: CC0 Public Domain

Last year, researchers Tobias Cronberg and Niklas Mattsson at Lund University in Sweden published a study showing serum tau levels to be a new and promising marker for identifying patients with severe brain damage after cardiac arrest. Together with Marion Moseby Knappe, they have now discovered that the protein Neurofilament light (NFL) in serum constitutes an even better marker to identify the degree of brain damage after cardiac arrest. This information could form the basis for decisions on continuing life-support treatment.

The study is an international collaboration including research colleagues from the Sahlgrenska Neurochemistry laboratory in Mölndal. Samples from more than 700 patients that were part of the largest ever study on cardiac arrest, TTM, were included. The results are now published in the scientific journal JAMA Neurology.

"We investigated serum Neurofilament light (NFL) with the same new hypersensitive investigation technology as Tobias Cronberg and Niklas Mattsson used for tau. In this new study, we found that serum NFL was an excellent marker for identifying the degree of after cardiac arrest. We also compared NFL with three other biomarkers, including tau and other standard methods used to predict outcome in patients after cardiac arrest," says one of the lead authors of the study, Marion Moseby Knappe, who is a researcher at the Centre for Cardiac Arrest at Lund University and a neurologist at Skåne University Hospital in Lund, Sweden.

Patients who have been resuscitated after cardiac arrest are often unconscious for the first few days due to brain , and around half of them die. Using neurophysiological measurements, radiological and neurological examinations, physicians obtain a picture of the extent of the patient's brain damage. This information then forms the basis for decisions on continuing or terminating life-supporting treatment.

"The new method consists of a simple blood test and can make these assessments more secure," says Marion Moseby Knappe.

"However, it is important to emphasise that the method is new and has so far only been used in a research context. If these results can be confirmed in further studies, in future, it might be possible to assess prognosis for recovery after even earlier than we do today. Thereby, we could also spare and their loved ones unnecessary suffering and make healthcare more efficient," saysTobias Cronberg, professor and consultant neurologist at the Centre for Cardiac Arrest at Lund University and Skåne University Hospital.

In this study, the level of NFL in the blood was a better marker for damage than any of the available methods currently in clinical use, according to the researchers behind the study.


Explore further

Tau may predict neurological outcome after cardiac arrest

More information: Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest. JAMA Neurol. Published online October 29, 2018. DOI: 10.1001/jamaneurol.2018.3223
Journal information: Archives of Neurology

Provided by Lund University
Citation: New and better marker for assessing patients after cardiac arrest (2018, October 31) retrieved 14 November 2019 from https://medicalxpress.com/news/2018-10-marker-patients-cardiac.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
6 shares

Feedback to editors

User comments